Evidence map›Paper›PMID 36567228›Full record

ReviewTrends in endocrinology and metabolism: TEM2023

Ghrelin receptor signaling in health and disease: a biased view.

Joshua D Gross, Yang Zhou, Lawrence S Barak, Marc G Caron

Abstract readReview
In one paragraph

Review in Trends in endocrinology and metabolism: TEM, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. LEAP2 as a therapeutic target in obesity and cardiometabolic disorders.Reviews in endocrine & metabolic disorders · 2026
    Review
  4. Article
  5. Review
  6. GHSR-Targeted PET Imaging Probe.ACS medicinal chemistry letters · 2026
    Article
  7. Biased Allosteric Modulation in GPCR Drug Discovery.Handbook of experimental pharmacology · 2026
    Review
  8. Missense Variants in Nutrition-Related Genes: A Computational Study.International journal of molecular sciences · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Ghrelin Modulates Voltage-Gated CaMolecular pharmacology · 2024
    Article
  14. Review
  15. Dopamine DNeuroscience · 2024
    Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Joshua D GrossDepartment of Cell Biology, Duke University, Durham, NC 27710, USA.
Yang ZhouDepartment of Cell Biology, Duke University, Durham, NC 27710, USA.
Lawrence S BarakDepartment of Cell Biology, Duke University, Durham, NC 27710, USA. Electronic address: lawrence.barak@duke.edu.
Marc G CaronDepartment of Cell Biology, Duke University, Durham, NC 27710, USA.

Funding

A novel functionally selective drug for the treatment of cocaine abuse by antagonism of the beta-arrestin signaling arm of the Ghrelin ReceptorU18DA052417 · NIDA · DUKE UNIVERSITY · PI BARAK, LAWRENCE S. · 2020 to 2020
$242k
Exploiting Biased Agonism at the Ghrelin Receptor (GHSR1a) for Opioid AddictionF32DA051139 · NIDA · DUKE UNIVERSITY · PI GROSS, JOSHUA D · 2020 to 2022
$201k
NIDA NIH HHS F32 DA051139NIDA NIH HHS U18 DA052417
6 · The paper itself

Abstract

As allosteric complexes, G-protein-coupled receptors (GPCRs) respond to extracellular stimuli and pleiotropically couple to intracellular transducers to elicit signaling pathway-dependent effects in a process known as biased signaling or functional selectivity. One such GPCR, the ghrelin receptor (GHSR

Indexed as

Receptors, GhrelinSignal TransductionGhrelinHumansGhrelinReceptors, Ghrelinbiased signalingfunctional selectivityghrelinGHSR(1a)GPCR

Identifiers

PMID36567228
PMCPMC9852078

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.